US EditionAlzheimer’s Drug Makes Unexpected Comeback After Initial Failure
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
The Andalusian Confederation of Alzheimer's (ConFeafa) has called in the Parliament of Andalusia for non-pharmacological therapies (TNF) to be recognized as a resource in the Dependency Law. In this regard, representatives of the entity, who have appeared in the Commission on the Rights and Care of Persons with Disabilities, have highlighted the importance of this type of therapies to prevent and slow cognitive deterioration when people with dia…
Alzheimer’s Drug Makes Unexpected Comeback After Initial Failure
After initial setbacks in clinical trials, a medication once deemed ineffective for Alzheimer’s disease is drawing renewed interest. Recent developments have sparked cautious optimism among researchers and families affected by this devastating neurodegenerative condition.
A once-abandoned drug is experiencing a resurgence of interest after showing promising results against Alzheimer's disease, offering new perspectives in the fight against this neurodegenerative disorder that affects millions of people worldwide.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
